SCPHARMACEUTICALS INC. Net Change in Cash
SCPHARMACEUTICALS INC. reported Net Change in Cash of -$34.85 million for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-07.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2025-08-07
- SCPHARMACEUTICALS INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2025-03-31 was -$18.11M, a 255.69% decline year-over-year.
- SCPHARMACEUTICALS INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2024-03-31 was $11.63M, a 176.32% increase year-over-year.
- SCPHARMACEUTICALS INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2023-03-31 was $4.21M.
- SCPHARMACEUTICALS INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2022-03-31 was -$22.64M, a 663.41% decline year-over-year.
- SCPHARMACEUTICALS INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2024 was $28.84M.
- SCPHARMACEUTICALS INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2023 was -$24.43M.
- SCPHARMACEUTICALS INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2022 was -$3.21M, a 230.95% decline from fiscal 2021.
- SCPHARMACEUTICALS INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2021 was $2.45M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2025-06-30 | -$34.85M 10-Q · filed 2025-08-07 | |||
| 2025-03-31 | -$18.11M 10-Q · filed 2025-05-14 | |||
| 2024-12-31 | $28.84M 10-K · filed 2025-03-19 | |||
| 2024-09-30 | $44.67M 10-Q · filed 2024-11-13 | |||
| 2024-06-30 | -$8.31M 10-Q · filed 2025-08-07 | |||
| 2024-03-31 | $11.63M 10-Q · filed 2025-05-14 | |||
| 2023-12-31 | -$24.43M 10-K · filed 2025-03-19 | |||
| 2023-09-30 | -$36.20M 10-Q · filed 2024-11-13 | |||
| 2023-06-30 | $107.00K 10-Q · filed 2024-08-14 | |||
| 2023-03-31 | $4.21M 10-Q · filed 2024-05-14 | |||
| 2022-12-31 | -$3.21M 10-K · filed 2024-03-13 | |||
| 2022-09-30 | -$32.98M 10-Q · filed 2023-11-08 | |||
| 2022-06-30 | -$33.09M 10-Q · filed 2023-08-10 | |||
| 2022-03-31 | -$22.64M 10-Q · filed 2023-05-10 | |||
| 2021-12-31 | $2.45M 10-K · filed 2023-03-22 | |||
| 2021-09-30 | $7.50M 10-Q · filed 2022-11-09 | |||
| 2021-06-30 | $3.15M 10-Q · filed 2022-08-09 | |||
| 2021-03-31 | $4.02M 10-Q · filed 2022-05-16 | |||
| 2020-12-31 | -$805.00K 10-K · filed 2022-03-22 | |||
| 2020-09-30 | -$28.35M 10-Q · filed 2021-11-09 | |||
| 2020-06-30 | $6.24M 10-Q · filed 2021-08-11 | |||
| 2020-03-31 | $2.71M 10-Q · filed 2021-05-12 | |||
| 2019-12-31 | -$16.85M 10-K · filed 2021-03-23 | |||
| 2019-09-30 | -$5.92M 10-Q · filed 2020-11-16 | |||
| 2019-06-30 | -$10.01M 10-Q · filed 2020-08-13 | |||
| 2019-03-31 | -$6.10M 10-Q · filed 2020-05-12 | |||
| 2018-12-31 | -$28.82M 10-K · filed 2020-03-24 | |||
| 2018-09-30 | -$23.00M 10-Q · filed 2019-11-12 | |||
| 2018-06-30 | -$17.53M 10-Q · filed 2019-08-07 | |||
| 2018-03-31 | -$9.02M 10-Q · filed 2019-05-08 | |||
| 2017-12-31 | $79.20M 10-K · filed 2019-03-21 | |||
| 2017-09-30 | -$7.26M 10-Q · filed 2018-11-13 | |||
| 2017-06-30 | -$1.20M 10-Q · filed 2018-08-14 | |||
| 2017-03-31 | -$4.75M 10-Q · filed 2018-05-07 | |||
| 2016-12-31 | $37.71M 10-K · filed 2019-03-21 |